Clovis Oncology Inc
CLVSQ·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$0.02
Today
+0.0%
YTD
+0.0%
About
Operating internationally, Clovis Oncology is a biotechnology company that acquires, develops, and commercialises anti-cancer agents. The company focuses on delivering the right drug to the right patient at the right time. Founded in 2009, the company has headquarters in Boulder, Colorado. Listed on the NASDAQ GS, the company's stock has the ticker of CLVS. Follow CLVS share price movements by tracking this stock with your eToro watchlist.
Price chart
Closing price history for CLVSQ (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-0.01
P/S (TTM)0.02
P/B (TTM)-0.01
Market cap$2.17M
Cap tierMicro-cap
Industry avg P/E-43.27
Profitability
Gross margin72.21%
EBIT margin-155.38%
Net margin-182.68%
ROE-547.56%
ROA-58.94%
Earnings & Revenue
Revenue (TTM)$133.02M
Revenue growth (1Y)-14.8%
EPS (TTM)-$1.82
Free cash flow$-175.84M
Total debt$680.62M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)2.23
Employees413
Next earnings22 Feb '23
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.